Infographic – The Complex Journey of a Vaccine
About IFPMA
IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere.
ifpma.org
To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health.
Related news and resources
Adult immunization: A critical investment for health, equity, and economic resilience
Immunization is an effective public health strategy to help prevent and reduce the impact of infectious diseases throughout the life course. As populations age and non-communicable diseases (NCDs) increase, our societies are becoming more vulnerable to preventable infectious diseases. This can put a significant strain on health systems, societies, and economies. Vaccines are wide recognized...
Read more
High-level interactive dialogue on the social, economic, and environmental determinants of health
On 11 July 2025 in New York at the UN Headquarters, IFPMA delivered a statement at the High-Level Dialogue on the Determinants of Health. Innovation in public health is essential to addressing the social, economic, and environmental determinants of health. IFPMA welcomes this dialogue and underscores the importance of collaboration to address complex health challenges,...
Read moreThe pharmaceutical industry supports Gavi’s high-level pledging meeting
On 25 June 2025, Gavi, the Vaccine Alliance, is co-hosting the Global Summit: Health & Prosperity through Immunization in support of its next five-year strategic period, in partnership with the European Union and the Gates Foundation.
Read more